Allogene Therapeutics
Dante Montenegro Jr is an accomplished professional in the field of research and development quality, currently serving as the Executive Director of R&D Quality at Allogene Therapeutics since March 2023. Prior experience includes leadership roles at Instil Bio as Senior Director of R&D Quality and Compliance, Ionis Pharmaceuticals as Director of Clinical Quality Assurance and Compliance, Ultragenyx as Associate Director of Clinical Quality Assurance, and Genentech as Senior Quality and Compliance Manager/Senior International Auditor. Dante holds a Bachelor’s Degree in Biopsychology from UC Santa Barbara and a Master of Business Administration in Technology Management from the University of Phoenix.
This person is not in any teams
This person is not in any offices